6th National Myeloma Scientific Workshop

The Myeloma Australia 2026 Scientific Workshop will be held on 1–2 May 2026 at Novotel Melbourne on Collins, bringing together experts to explore the next steps on the path to cure.

Two people are sitting at a tabling looking watching a conference. The person in the foreground is wearing a lanyard, there is coffee on the table.

Next Steps on the Path to Cure

May 1-2, 2026

Novotel Melbourne on Collins
270 Collins St,
Melbourne VIC 3000

Myeloma Australia is proud to announce the 2026 Scientific Workshop, taking place on May 1–2, 2026, at Novotel on Collins in Melbourne, Victoria.

This year’s theme, Next Steps on the Path to Cure, will bring together healthcare professionals, scientists, and researchers to explore the latest advancements in myeloma care.

Day 1 will open in the evening from 5:00 pm – 9:30 pm with a session focused on clinical trials, followed by a delegate dinner for networking and collaboration.

Day 2 offers a full-day program from 8:30 am – 5:30 pm featuring cutting-edge scientific research and innovative approaches to treatment and the path to cure. Our lineup includes leading national and international experts, showcasing advancements in myeloma research and care.

Early-bird tickets are now sold outMake sure to secure your place today! 


Novotel on Collins is conveniently located 400 metres from Flinders Street Railway Station and there are many accommodation options in the area.

For on-site accomodation with Novotel, please book via this link.

Directions to the venue are on their website

Programme

Time (AEST)TopicSpeaker
17:00 – 17:30Welcome / The MM research landscape in AustraliaMyeloma Australia CEO Mr. Mark Henderson

MSAG Chair Prof. Simon Harrison
17:30–18:00MRDR update and current research projectsProf. Andrew Spencer
18:00 – 18:30AMaRC Current and Upcoming TrialsProf. Hang Quach
18:30ALLG Current and Upcoming TrialsDr. Georgia McCaughan

Time (AEST)TopicSpeaker
19:00 – 21:30Welcome Dinner and Panel DiscussionMr. Mark Henderson,
Prof. Simon Harrison,
Dr. Nicholas Weber,
Prof. Andrew Spencer,
Dr. Suzanne Trudel,
Dr Charlotte Palwyn

Session Chair: TBC

Time (AEST)TopicSpeaker
08:30 – 09:00Functional genomic approaches to novel treatment target identificationDr Jacqueline Noll
09:00 – 09:30Novel disease markersDr. Durga Mithraprabhu
09:30 – 9:45TBCTBC
09:45 – 10:00Q&A Panel

Session Chair: TBC

Time (AEST)TopicSpeaker
10:30 – 11:00Mechanisms of extramedullary myelomaDr. Nick Bingham
11:00 – 11:30Microenvironmental factors affecting CART functionTBC
11:30 – 11:45TBCTBC
11:45 – 12:00TBCTBC
12:00 – 12:15TBCTBC
Q&A Panel

Session Chair: TBC

Time (AEST)TopicSpeaker
10:30 – 11:00ElranatamabTBC
11:00 – 11:40BelantamabGSK representatives
11:40 – 12:10Cilta-celTBC
12:10 – 12:30Building CAR-T–ready hospitals: nursing protocols, escalation frameworks, and workforce capabilityMs. Cassie Abbott

Session Chair: TBC

Time (AEST)TopicSpeaker
13:30–14:30Research priorities and unanswered questions in the era of BCMA immunotherapyDr. Suzanne Trudel
14:30–14:50TBCTBC
14:50–15:00Q&A Panel

Session Chair: TBC

Time (AEST)TopicSpeaker
15:30 – 16:15Understanding treatment resistance and optimising treatment durationDr. Charlotte Pawlyn
16:15 – 16:45Evidence based MRDProf Andrew Spencer
16:45 – 17:00Q&A Panel
17:00 – 17:30Award presentation / Event Close

Sponsors

GSK LOGO
Pfizer logo
Sebia The New Language of life logo
Abbvie logo
Arrotext logo
Roche logo
Bristol Myers Squibb logo
Gilead Kite logo

Telephone Support Line

Talk directly with our specialist myeloma nurses who understand exactly what you’re going through.

Use our simple booking form below to schedule your personalised consultation at a time that works for you.

Get the expert guidance and emotional support you need, when you need it most.